OSL GROUP LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.92 HKD | +1.74% |
|
+2.81% | -18.83% |
| Apr. 19 | OSL Group Limited Announces the Resignation of Yang Yu as Independent Non-Executive Director | CI |
| Apr. 18 | OncoSil Medical Treats Two More Patients in Netherlands in Pancreatic Cancer Trial | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- Low profitability weakens the company.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Blockchain & Cryptocurrency
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -18.83% | 780M | - | ||
| +28.57% | 54.18B | - | ||
| +15.97% | 6.99B | - | - | |
| -27.69% | 729M | - | ||
| +126.19% | 613M | - | - | |
| +245.20% | 507M | - | - | |
| -49.12% | 354M | - | - | |
| -13.56% | 121M | - | ||
| -.--% | 118M | - | - | |
| -9.33% | 109M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 863 Stock
- Ratings OSL Group Limited
